<DOC>
	<DOCNO>NCT00280475</DOCNO>
	<brief_summary>The aim study evaluate non-inferiority salvage stereotactic radiosurgery ( SRS ) patient receive surgical resection brain metastasis comparison postoperative whole brain radiation therapy ( WBRT ) .</brief_summary>
	<brief_title>A Trial Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy Metastasis</brief_title>
	<detailed_description>A randomized phase III study start Japan compare postoperative whole brain radiation therapy salvage stereotactic radiosurgery patient one four brain metastasis lung , breast , colorectal cancer . Total 270 patient accrue study 21 institution within three year . The primary endpoint overall survival . The secondary endpoint proportion performance status ( PS ) preservation , proportion mini-mental status examination ( MMSE ) preservation , adverse event .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1. one four brain metastasis maximum diameter 3 cm large lesion additional lesion exceed 3 cm diameter 2. brain metastasis localize within cerebrum cerebellum 3. surgical resection brain metastasis , PS 02 , 3 cerebral nerve compression neurological deficit 4. surgical resection large brain metastasis achieve 5. surgical resection , four few ( 04 ) residual lesion maximum diameter 3 cm 6. histologically proven nonsmall cell carcinoma , breast cancer colorectal cancer 7. primary lesion metastasis ( i.e . lung , liver , bone metastasis except brain ) consider control 8. age 2079 year 9. prior surgery irradiation brain 10. adequate organ function 11. write inform consent ( If sign consent form difficult patient due paralysis , sign family place patient permit ) 1. synchronous metachronous ( within 5 year ) malignancy carcinoma situ mucosal cancer 2. pregnant breastfeed woman 3. severe mental disease 4. allergic gadolinium contain contrast agent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Randomized Controlled Trials</keyword>
	<keyword>Brain Neoplasms/Secondary</keyword>
	<keyword>Brain Neoplasms/Radiotherapy</keyword>
	<keyword>Radiosurgery</keyword>
</DOC>